BALTIMORE, April 1, 2010 (GLOBE NEWSWIRE) -- Goldman Small Cap Research, a stock market research firm focused on the small cap and micro cap sectors, has issued a research update on Implant Sciences Corporation (OTCBB:IMSC), a provider of explosive trace detection systems.
Implant Sciences produces explosive trace detection systems that have been sold and are in use by law enforcement and public safety agencies around the world. The Company's offerings are used in aviation security, ground transportation security, and by military and civilian agencies.
In the Goldman Opportunity Research updated report on the Company, analyst Rob Goldman notes that the Company not only may be on a TSA-approved list of providers for explosive trace detection systems for air cargo, but recent events have helped the Company's overall positioning.
According to Goldman Small Cap Research analyst Rob Goldman, "The first 12 months following such approval could be worth as much as $20-$25M, and add $10M+ in net income. Furthermore, if our preliminary net income contribution is accurate, that alone would ultimately afford IMSC a $300M valuation."
The Company addresses unmet needs in large markets with a clever, proprietary, non-radioactive ionization mechanism. Furthermore, the Company's flagship has demonstrated tremendous operational efficacy and overall cost-effectiveness as compared to its competition. This is due to the fact that Implant Sciences has the largest substance library in the space, and its products require no consumables. In our view, the Street has overlooked the Company's unique positioning and potential to be a market share leader.
To view a summary of the report or download the report in its entirety, please visit www.goldmanresearch.com.
About Goldman Small Cap Research: Led by former Piper Jaffray analyst and mutual fund manager Rob Goldman, Goldman Small Cap Research produces stock market research reports. The Firm produces research via two formats: Goldman Select Research and Goldman Opportunity Research. The Select product reflects the Firm's internally generated stock ideas while the Opportunity product reflects sponsored research reports. While performance is tracked separately, the same coverage criteria are utilized in determining coverage of all stocks in both research formats.
A Goldman Small Cap Research report is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed. Please read the report's full disclosures and analyst background on our website before investing. Neither Goldman Small Cap Research nor its parent is a registered investment adviser or broker-dealer. To download our research or for more information, visit www.goldmanresearch.com.
About Implant Sciences Corporation: Implant Sciences develops, manufactures and sells sophisticated sensors and systems for the Security, Safety and Defense (SS&D) industries. The Company has developed proprietary technologies used in its commercial portable and bench-top explosive trace detection systems which ship to a growing number of locations domestically and internationally. For more information, visit www.implantsciences.com.